Abstract

Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)

Author(s): Riepl Mike

Issue: May/Jun 2019 - Volume 23, Number 3

Page(s): 192-199

Download in electronic PDF format for $75
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 1
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 2
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 3
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 4
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 5
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 6
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 7
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 8

Abstract

Polycystic ovary syndrome (Stein- Leventhal syndrome) is a common endocrinopathologic condition in reproductive- age women in the U.S. Patients with that disease are not faced with treatment choices for a single medical entity; they must manage a constellation of comorbid conditions that compromise their overall health and diminish their quality of life. The combinations of those disorders are unique to each patient. As a result, the safest and most effective therapeutic approach often requires precision pharmacy: the use of compounded therapies that, unlike commercially manufactured medications, can be precisely adjusted to meet individual needs and modified as therapeutic requirements change. In this article, the manifestations of polycystic ovary syndrome are reviewed, several common concomitant conditions are discussed, therapeutic interventions are suggested, and compounded formulations are provided.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2019
Pg. 192-199
Author(s): Riepl Mike
Jan/Feb 2003
Pg. 27-29
Author(s): Vail Jane
Jul/Aug 2015
Pg. 289-293
May/Jun 2016
Pg. 197-201
Mar/Apr 2018
Pg. 172-175
May/Jun 2007
Pg. 187-192
Author(s): Vail Jane
May/Jun 2010
Pg. 182-192
Jul/Aug 2005
Pg. 259-264
View Sample
Author(s): Tan Robert S
Jan/Feb 2010
Pg. 40-45
Sep/Oct 2022
Pg. 378-384
Sep/Oct 2020
Pg. 367-369
May/Jun 2012
Pg. 196-205
Author(s): Zur Eyal
Nov/Dec 2013
Pg. 446-450
Sep/Oct 2014
Pg. 370-377
Mar/Apr 2001
Pg. 136-139
Author(s): Filicpzuk Janina
Sep/Oct 1999
Pg. 344-348
Author(s): Milner Martin
Sep/Oct 1999
Pg. 366-367
Author(s): Long Scott F
Sep/Oct 2000
Pg. 334
Author(s): Mathews Elizabeth
Sep/Oct 2000
Pg. 338
Author(s): Dyke Shannon
Sep/Oct 2000
Pg. 349
Author(s): Hinze John, Mahan Tracy